USA flag logo/image

An Official Website of the United States Government

CARDIOMYOPATHY OF IRON OVERLOAD--FIRST ANIMAL MODEL

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
19201
Program Year/Program:
1992 / SBIR
Agency Tracking Number:
19201
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Zivic Miller Laboratories Inc
3848 Hieber Road Allison Park, PA 15101
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1992
Title: CARDIOMYOPATHY OF IRON OVERLOAD--FIRST ANIMAL MODEL
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THIS RESEARCH PROJECT IS DESIGNED TO ESTABLISH THE TECHNICAL MERIT AND FEASIBILITY OF COMMERCIAL PRODUCTION OF RATS WITH THE CARDIOMYOPATHY OF IRON OVERLOAD. PILOT STUDIES WITH OUR CONSUTANTS HAVE SHOWN THAT CARDIAC IRON DEPOSITION NEAR THE MAGNITUDE ASSOCIATED WITH ARRHYTHMIAS AND CONGESTIVE HEART FAILURE IN PATIENTS WITH IRON OVERLOAD CAN BE PRODUCED IN RATS. THESE STUDIES ARE DESIGNED TO DEMONSTRATE THAT THE MAGNITUDE AND PATTERN OF CARDIAC IRON DEPOSITION AS WELL AS THE FUNCTIONAL IMPAIRMENT FOUND WITH THE CARDIOMYOPATHY OF HUMAN IRON OVERLOAD CAN BE REPRODUCED IN THE RAT. THE RESEACH WILL DEVELOP A NEW METHOD FOR PRODUCING SYSTEMIC IRON OVERLOAD IN THE RAT THAT WILL BE ABLE TO REPRODUCE WITHIN MONTHS A CARDIMYOPATHY THAT TAKES YEARS TO DEVELOP IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD OR HEREDITARY HEMOCHROMATOSIS. THESE ANIMALS WITH IRON-INDUCED CARDIOMYOPATHY WOULD THEN BE MADE COMMERCIALLY AVAIIALABLE TO INVESTIGATORS FORSPECIALIZED STUDIES.

Principal Investigator:

George S Miller
4123649495

Business Contact:

Small Business Information at Submission:

Zivic Miller Laboratories Inc
3848 Hieber Road Allison Park, PA 15101

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No